Ovid Therapeutics Inc. OVID
Super Investor & Insider
Nessuna transazione insider negli ultimi 6 mesi.
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Ovid Therapeutics Inc. is a biopharmaceutical company focused on developing small molecule medicines for brain conditions characterized by excess neural excitability, such as rare neurological disorders, epilepsies, and seizure-related issues. The company advances a pipeline targeting neuronal hyperexcitability to rest…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees23
TickerOVID
Statistics
Market Cap$408.1M
Revenue (TTM)$7.3M
Net Income-$17.4M
Net Margin-240.1%
EPS—
P/E-9.61
P/S63.42
P/B2.41
EV/EBITDA-6.42
ROE-18.8%
Dividend Yield—
Price$2.44
Data: Twelve Data · Revenue = mcap / P/S